PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 31 filers reported holding PROTARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106,880 | -30.1% | 64,000 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $152,960 | -22.9% | 64,000 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $198,400 | +15.7% | 64,000 | 0.0% | 0.01% | +25.0% |
| Q4 2022 | $171,520 | -9.2% | 64,000 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $189,000 | +0.5% | 64,000 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $188,000 | -42.5% | 64,000 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $327,000 | -9.4% | 64,000 | +19.6% | 0.01% | -14.3% |
| Q4 2021 | $361,000 | -53.7% | 53,500 | -52.4% | 0.01% | -53.3% |
| Q3 2021 | $779,000 | – | 112,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,558,472 | $43,059,000 | 8.42% |
| CVI Holdings, LLC | 168,836 | $2,842,000 | 1.16% |
| Soleus Capital Management, L.P. | 100,000 | $1,683,000 | 0.89% |
| Ikarian Capital, LLC | 722,443 | $12,158,000 | 0.88% |
| COWEN AND COMPANY, LLC | 124,171 | $2,090,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 782,670 | $13,172,000 | 0.32% |
| Cormorant Asset Management, LP | 450,000 | $7,574,000 | 0.29% |
| Rock Springs Capital Management LP | 643,622 | $10,832,000 | 0.28% |
| Perceptive Advisors | 608,544 | $10,242,000 | 0.15% |
| Maven Securities LTD | 100,000 | $1,688,000 | 0.14% |